Navigation Links
Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimer's Disease and Other Proteinopathies
Date:10/26/2011

or of the CONJUMAB-A technology.  "While CONJUMAB-A is still at the earliest stage of development and requires substantial work before new drug candidates can be tested in human clinical trials, we are very optimistic regarding its potential, and look forward to reporting our progress as soon as possible."

Intellect's new platform may also have applications for in vivo imaging of amyloid, which may be useful for diagnosis of disease and monitoring of drug effectiveness. The Company has applied for a patent for its CONJUMAB-A technology. Intellect has the exclusively license to certain patents granted by the USPTO to NYU School of Medicine and the University of South Alabama Research Foundation specifically covering the use of melatonin for the treatment of Alzheimer's disease and other types of amyloidosis. The CONJUMAB-A platform is applicable to a broad range of diseases including, Alzheimer's, Parkinson's, Huntington's, Age-Related Macular Degeneration, Glaucoma, Cerebral Angiopathy, Frontotemporal Dementia, Progressive Supranuclear Palsy, Pick's disease, Cortical Basal Degeneration and Peripheral Amyloidosis.

About Intellect Neurosciences, Inc.

Intellect Neurosciences, Inc. develops innovative approaches aimed at arresting or preventing Alzheimer's disease, and other neurodegenerative diseases especially focused on proteinopathies. Intellect's pipeline includes small neuroprotective molecules and neoepitope-based immunotherapy approaches including monoclonal antibodies and vaccines targeting beta amyloid and abnormal tau proteins. Previously, Intellect Neurosciences out-licensed late-stage antibody products based on the company's ANTISENILIN® Alzheimer's beta amyloid monoclonal antibody technology to several major pharmaceutical companies. In addition, the company recently licensed OX1 a small molecule antioxidant to ViroPharma Incorporated for Friedreich's Ataxia and other neurodegenerative diseases. Currently, the company
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intellect Neurosciences Issues Letter to Shareholders
2. Intellect Neurosciences CEO to be Featured on Wall Street Reporter
3. ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreichs Ataxia
4. IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics, Inc.
5. PILMA Vows to Redouble Support for Increased Protections Against Intellectual Property Theft
6. Dehaier Strengthens Intellectual Property Portfolio
7. NMT Medical, Inc. Adds Intellectual Property to Its Sealed Bid Sale of Friday, June 10, 2011 at Twelve OClock Noon
8. GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling
9. Inovio Pharmaceuticals Market-Leading Intellectual Property Recognized by MDB Capital Award
10. NMT Medical, Inc. Sealed Bid Sale of its Intellectual Property to Take Place Friday, June 10, 2011 at Twelve OClock Noon
11. Software Development Firms New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- Hologic, Inc. (NASDAQ: HOLX ), today announced ... Executive Officer, will preside over the NASDAQ Stock Market ... of Breast Cancer Awareness Month. In his remarks, Mr. ... important benefits of Hologic,s 3D Mammography technology, the only ... to traditional mammography. This is the ninth ...
(Date:9/30/2014)... -- This study provides an analysis of the ... nuclear imaging informatics, PET imaging informatics, and multimodality ... size of the market based on its historic ... growth based on the current drivers and restraints, ... the broader markets for imaging equipment, advanced visualization, ...
(Date:9/30/2014)... 30, 2014 Aileron Therapeutics, Inc. - ... Global Markets Direct,s, ,Aileron Therapeutics, Inc. - Product ... the Aileron Therapeutics, Inc.,s pharmaceutical research and development ... the current therapeutic developmental pipeline of Aileron Therapeutics, ... therapeutics assessment by drug target, mechanism of action ...
Breaking Medicine Technology:Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3
... 5th is a great day to quit smoking for good.  There are more ... 7,200 of them die from a tobacco-related illness.(1) As of July 5 , ... free law that took effect in all restaurants, bars and workplaces.(2) , ... Research shows that policy changes, like the new statewide smoke-free law, ...
... 6 Reportlinker.com announces that a new market research report is available ... Opportunities ... , , ... , , ...
Cached Medicine Technology:Wisconsin Statewide Smoke-Free Law May Prompt Smokers to Quit 2Wisconsin Statewide Smoke-Free Law May Prompt Smokers to Quit 3Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 2Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 3Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 4Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 5Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 6Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 7Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 8Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 9Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 10Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 11
(Date:10/1/2014)... Scientists at the University of Western ... immune system proteins has the power to knock out ... of the new study on their website. Click ... in the UWA School of Pathology and Laboratory Medicine ... with mesothelioma with promising results. , “A timed ...
(Date:10/1/2014)... October 01, 2014 Nordic Naturals ... a very special cause. The campaign—“Buy One Bottle. ... Paws for Veterans, a nonprofit organization that helps ... rescuing shelter dogs that would otherwise face euthanasia. ... products will support monthly donations of Nordic Naturals ...
(Date:10/1/2014)... October 01, 2014 Dr. Saj Jivraj, ... and prosthodontists, is traveling to Chennai, India, tomorrow to ... Oct. 2 and 3. , Dr. Jivraj is founder ... and Oxnard, Calif., and one of the world’s foremost ... and replacement. He is speaking to the Indian Society ...
(Date:10/1/2014)... Generic drug prices are on the ... price in the last 12 months. For its Sept. ... News (DBN) interviewed a plan sponsor and a financial ... health plans. , “When MAC [maximum allowable cost] ... these cost increases squeeze pharmacies’ profits,” explains Adam Fein, ...
(Date:10/1/2014)... This October, Request A Test , ... is offering 10% off all testing for Diabetes . ... order to save. The Center for Disease Control (CDC) ... affected by Diabetes. Because many people do not display ... it causes serious health problems. Blood testing can help ...
Breaking Medicine News(10 mins):Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Nordic Naturals® Inspires Support for Paws for Veterans -- ‘Buy One Bottle. Help Two Heroes.’ Initiative Kicks Off October 1 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 3Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 4Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 5Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 2Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 3Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 2Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 3
... Kathleen Doheny HealthDay Reporter , WEDNESDAY, Oct. ... States are less likely to breast-feed their babies than ... the bottle as the primary reason, new research finds. ... disparity between ethnic groups persists, said Dr. Amudha ...
... consensus statement published in the September, 2010, issue of ... Metabolism ( JCEM ) finds that the increasing ... than commonly believed suggests that regular glycemia screening, early ... aggressive intervention deserves greater emphasis. The consensus ...
... The Michael J. Fox Foundation for Parkinson,s Research announced ... studies and 14 pre-clinical therapeutic development projects. The funding ... under the Clinical Intervention Awards, one of the Foundation,s ... Grantees under the 2010 Clinical Intervention Awards are: ...
... HealthDay Reporter , TUESDAY, Oct. 5 (HealthDay News) -- ... admit they are binge drinkers, health officials said Tuesday. ... four or more drinks for women, and five or more ... that are different because men and women metabolize alcohol differently. ...
... Cancer Care is hosting the 42nd Congress of the International ... in the world, SIOP is returning to the United States ... Thursday, Oct. 21, through Sunday, Oct. 24, 2010, Media room ... Saturday, and 8 a.m. to 3 p.m. Sunday. Location: ...
... plaque debris could trigger a "paradigm shift" in how physicians ... of Endovascular Today . "We will see a ... of Loyola University Health System and Dr. Aravinda Nanjundappa of ... patients, the device had a success rate of 97 percent ...
Cached Medicine News:Health News:Breast-Feeding Less Common for Black Moms 2Health News:Breast-Feeding Less Common for Black Moms 3Health News:Experts advocate realigning type 2 diabetes treatments with disease's natural history 2Health News:MJFF announces over $10 million in funding for clinical and pre-clinical PD research 2Health News:1 in 4 U.S. Teens and Young Adults Binge Drink: CDC 2Health News:1 in 4 U.S. Teens and Young Adults Binge Drink: CDC 3Health News:Boston, Oct. 21-24: Largest international pediatric oncology conference 2Health News:'Paradigm shift' in how physicians treat peripheral artery disease 2
0-3.5 LPM Oxygen Flowmeter with Ohmeda male inlet...
0-15 LPM Oxygen Flowmeter with Chemetron male inlet...
... Click style oxygen flowmeters., ... add suffix S to model ... Canadian Color-Code, add suffix C ... , For Double Flowmeters with ...
... Slim Line Flowmeters with brass ... For security chain, add suffix S ... For Canadian Color-Code, add suffix C ... For Double Flowmeters with Power Take-Off, ...
Medicine Products: